Invivyd, Inc.
Qualité des données : 100%
IVVD
NASDAQ
Manufacturing
Chemicals
1,71 €
0,00 €
(0,00%)
6 months return
—
Momentum
Neutral
ROE
-77,27%
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)110,47%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-77,27%
En dessous de la moyenne du secteur (-54,68%)
ROIC-63,00%
Net Margin-98,25%
Op. Margin-103,99%
Sécurité
Debt / Equity
N/A
Current Ratio2,47
Interest CoverageN/A
Valorisation
PE (TTM|NTM)
-9,48 | -7,77
En dessous de la moyenne du secteur (-1,49)
P/B Ratio5,34
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Negative free cash flow of -58,29 M
Capital efficient — spends only 0,29% of revenue on capex
Price History
Tendances Financières
Objectif de Cours des Analystes
3 analystes
Buy
+484.8%
upside to target
Actuel
1,71 €
Consensus Target
10,00 €
10,00 €
Bas
10,00 €
Haut
Prévisions
P/E Prévisionnel
-7,77
BPA Prévisionnel
-0,22 €
CA Est.
119,67 M
Surprises de Résultats
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -0,08 €
·
Rev Est: 18,05 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -0,14 € | -0,12 € | -0,06 € | — | — | — |
| Estimate | -0,01 € | 0,01 € | -0,10 € | -0,10 € | -0,08 € | -0,08 € |
| Surprise | -1300,00% | -1300,00% | +36,84% | — | — | — |
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | 110,47% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: -77,27% · Net Margin: -98,25%
Profitability
ROE: -77,27% · Net Margin: -98,25%| Revenue (TTM) | 53,43 M | Net Income (TTM) | -52,49 M |
| ROE | -77,27% | ROA | -45,98% |
| Gross Margin | N/A | Operating Margin | -103,99% |
| Net Margin | -98,25% | Free Cash Flow (TTM) | -58,29 M |
| ROIC | -63,00% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 2,47
Safety
D/E: N/A · Current: 2,47| Debt / Equity | N/A | Current Ratio | 2,47 |
| Interest Coverage | N/A | Asset Turnover | 0,47 |
| Working Capital | 65,27 M | Tangible Book Value | 93,07 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -9,48 · EV/EBITDA: N/A
Valuation
P/E: -9,48 · EV/EBITDA: N/A| P/E Ratio | -9,48 | Forward P/E | -7,77 |
| P/B Ratio | 5,34 | P/S Ratio | 9,31 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 4,16 | Fwd Earnings Yield | N/A |
| FCF Yield | -11,72% | ||
| Market Cap | 497,37 M | Enterprise Value | 412,40 M |
Per Share
EPS: -0,30 · FCF/Share: -0,21
Per Share
EPS: -0,30 · FCF/Share: -0,21| EPS (Diluted TTM) | -0,30 | Revenue / Share | 0,19 |
| FCF / Share | -0,21 | OCF / Share | -0,21 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 111,05% · CapEx/Rev: 0,29%
Efficiency
FCF Conv: 111,05% · CapEx/Rev: 0,29%| CapEx / Revenue | 0,29% | FCF Conversion | 111,05% |
| SBC-Adj. FCF | -70,23 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 53,43 M | 25,38 M | — | — | — |
| Net Income | -52,49 M | -169,93 M | -198,64 M | -241,32 M | -226,79 M |
| EPS (Diluted) | -0,30 | -1,43 | -1,81 | -2,23 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -55,56 M | -176,88 M | -212,76 M | -248,03 M | -226,91 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 38,31 M | 137,25 M | 158,66 M | 179,21 M | 182,89 M |
| SG&A Expenses | 66,93 M | 63,39 M | 49,13 M | 47,04 M | 36,52 M |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 276,88 M | 129,52 M | 229,18 M | 383,17 M | 620,09 M |
| Total Liabilities | 35,34 M | 61,98 M | 51,71 M | 27,20 M | 62,07 M |
| Shareholders' Equity | 241,54 M | 67,54 M | 177,47 M | 355,97 M | 558,02 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 226,69 M | 69,35 M | 200,64 M | 92,08 M | 542,22 M |
| Current Assets | 247,47 M | 100,68 M | 224,88 M | 376,92 M | 616,71 M |
| Current Liabilities | 34,16 M | 61,98 M | 50,29 M | 25,03 M | 62,06 M |
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs)
Par rapport à des entreprises similaires dans Manufacturing
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs) Par rapport à des entreprises similaires dans Manufacturing| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,5 | -1,5 |
| P/B | 5,3 | 1,6 |
| ROE % | -77,3 | -54,7 |
| Net Margin % | -98,3 | -41,5 |
| Rev Growth 5Y % | — | 1,7 |
| D/E | — | 0,3 |
ETFs Holding This Stock
ETFs Holding This Stock
DMCRX
DMCRX
0,47% weight
{"event":"ticker_viewed","properties":{"ticker":"IVVD","listing_kind":"stock","pathname":"/stocks/ivvd","exchange":"NASDAQ","country":"US"}}